Cargando…

Androgen Receptor-Dependent and -Independent Mechanisms Involved in Prostate Cancer Therapy Resistance

Despite the initial efficacy of androgen deprivation in prostate cancer, virtually all patients progress to castration-resistant prostate cancer (CRPC). Androgen receptor (AR) signaling is critically required for CRPC. A new generation of medications targeting AR, such as abiraterone and enzalutamid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Crona, Daniel J., Whang, Young E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5483886/ https://www.ncbi.nlm.nih.gov/pubmed/28604629 http://dx.doi.org/10.3390/cancers9060067

Ejemplares similares

Targeting androgen receptor-independent pathways in therapy-resistant prostate cancer
por: Xu, Lingfan, et al.
Publicado: (2019)

Posttranslational regulation of androgen dependent and independent androgen receptor activities in prostate cancer
por: Wen, Simeng, et al.
Publicado: (2020)

Mechanism of Anti-Cancer Activity of Curcumin on Androgen-Dependent and Androgen-Independent Prostate Cancer
por: Abd. Wahab, Nurul Azwa, et al.
Publicado: (2020)

Androgen Receptor-Dependent Mechanisms Mediating Drug Resistance in Prostate Cancer
por: Ehsani, Marzieh, et al.
Publicado: (2021)

Mechanisms of Androgen-Independent Prostate Cancer
por: Saraon, Punit, et al.
Publicado: (2014)

Loss of Fibroblast-Dependent Androgen Receptor Activation in Prostate Cancer Cells is Involved in the Mechanism of Acquired Resistance to Castration
por: Ishii, Kenichiro, et al.
Publicado: (2019)

Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer
por: Chuu, Chih-Pin, et al.
Publicado: (2011)

Regulation of expression of Na(+),K(+)-ATPase in androgen-dependent and androgen-independent prostate cancer
por: Blok, L J, et al.
Publicado: (1999)

Bypass Mechanisms of the Androgen Receptor Pathway in Therapy-Resistant Prostate Cancer Cell Models
por: Marques, Rute B., et al.
Publicado: (2010)

Overcoming the mechanisms of primary and acquired resistance to new generation hormonal therapies in advanced prostate cancer: focus on androgen receptor independent pathways
por: Bungaro, Maristella, et al.
Publicado: (2020)

Glucocorticoid receptor and androgen receptor-targeting therapy in patients with castration-resistant prostate cancer
por: Pak, Sahyun, et al.
Publicado: (2022)

Osteoblasts Promote Prostate Cancer Cell Proliferation Through Androgen Receptor Independent Mechanisms
por: Ribelli, Giulia, et al.
Publicado: (2021)

Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines
por: Wang, Yu, et al.
Publicado: (2010)

Androgen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles
por: Hoang, David T, et al.
Publicado: (2016)

Anticancer Imidazoacridinone C-1311 is Effective in Androgen-Dependent and Androgen-Independent Prostate Cancer Cells
por: Niemira, Magdalena, et al.
Publicado: (2020)

Integrin Involvement in Freeze Resistance of Androgen-Insensitive Prostate Cancer
por: Baust, John G., et al.
Publicado: (2010)

Experimental Evidence of Persistent Androgen-Receptor-Dependency in Castration-Resistant Prostate Cancer
por: Kobayashi, Takashi, et al.
Publicado: (2013)

Identification of key genes and specific pathways potentially involved in androgen-independent, mitoxantrone-resistant prostate cancer
por: Zhu, Sha, et al.
Publicado: (2019)

The Androgen Receptor and VEGF: Mechanisms of Androgen-Regulated Angiogenesis in Prostate Cancer
por: Eisermann, Kurtis, et al.
Publicado: (2017)

Metabolic Roles of Androgen Receptor and Tip60 in Androgen-Dependent Prostate Cancer
por: Tan, Kah Ni, et al.
Publicado: (2020)

Bicyclic Chalcones as Mitotic Inhibitors for Overcoming Androgen Receptor-Independent and Multidrug-Resistant Prostate Cancer
por: Saito, Yohei, et al.
Publicado: (2021)

ONECUT2 Activates Diverse Resistance Drivers of Androgen Receptor-Independent Heterogeneity in Prostate Cancer
por: Qian, Chen, et al.
Publicado: (2023)

Molecular mechanisms underlying resistance to androgen deprivation therapy in prostate cancer
por: Wadosky, Kristine M., et al.
Publicado: (2016)

Loss of Androgen Receptor-Dependent Growth Suppression by Prostate Cancer Cells Can Occur Independently from Acquiring Oncogenic Addiction to Androgen Receptor Signaling
por: D'Antonio, Jason M., et al.
Publicado: (2010)

Towards understanding androgen receptor-independent prostate cancer: an evolving paradigm
por: Zhou, Jianfu, et al.
Publicado: (2020)

Androgen Metabolism and Response in Prostate Cancer Anti-Androgen Therapy Resistance
por: Zhang, Haozhe, et al.
Publicado: (2022)

SHH-N non-canonically sustains androgen receptor activity in androgen-independent prostate cancer cells
por: Trnski, Diana, et al.
Publicado: (2021)

Bipolar Androgen Therapy Followed by Androgen Receptor Inhibition as Sequential Therapy for Prostate Cancer
por: Denmeade, Samuel R, et al.
Publicado: (2023)

Androgen receptor targeted therapies in castration‐resistant prostate cancer: Bench to clinic
por: Imamura, Yusuke, et al.
Publicado: (2016)

Androgen Receptor Targeted Therapy + Radiotherapy in Metastatic Castration Resistant Prostate Cancer
por: Massaro, Maria, et al.
Publicado: (2021)

Novel lipid mediators contributing to androgen receptor therapy resistance in prostate cancer
por: Chinni, Sreenivasa R.
Publicado: (2021)

Abiraterone switches castration‐resistant prostate cancer dependency from adrenal androgens towards androgen receptor variants and glucocorticoid receptor signalling
por: Moll, J. Matthijs, et al.
Publicado: (2022)

Arsenic and Prostate Cancer: Acquiring Androgen Independence
por: Tibbetts, John
Publicado: (2005)

Differential modulation of the androgen receptor for prostate cancer therapy depends on the DNA response element
por: Kregel, Steven, et al.
Publicado: (2020)

A novel approach to identify driver genes involved in androgen-independent prostate cancer
por: Schinke, Ellyn N, et al.
Publicado: (2014)

Discovery of ODM-201, a new-generation androgen receptor inhibitor targeting resistance mechanisms to androgen signaling-directed prostate cancer therapies
por: Moilanen, Anu-Maarit, et al.
Publicado: (2015)

The Evolution of Prostate Cancer Therapy: Targeting the Androgen Receptor
por: Aragon-Ching, Jeanny B.
Publicado: (2014)

Androgen deprivation therapy increases the sensitivity of human prostate carcinoma cells to T cell-mediated lysis through an androgen receptor dependent mechanism
por: Gameiro, Sofia, et al.
Publicado: (2014)

Menin Enhances Androgen Receptor-Independent Proliferation and Migration of Prostate Cancer Cells
por: Kim, Taewan, et al.
Publicado: (2022)

Androgen receptor-mediated upregulation of quaking affects androgen receptor-related prostate cancer development and anti-androgen receptor therapy
por: Zhang, Keke, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_t6a3p05dqn35qehlbvlc2i9em7